16 Nov 2025
byJairia Dela Cruz
For multiethnic Southeast Asian patients with acute coronary syndrome (ACS), bleeding outcomes including BARC type 3 bleeding appear to be less favourable with ticagrelor than with clopidogrel, as shown in a retrospective study from Singapore.